Clinical Trials in Arequipa, Ariqipa

Find clinical trials in Arequipa, Ariqipa. Discover local research opportunities and treatment options in your area.

8 Active Trials Found in Arequipa

Showing 8 trials on this page

Page 1 of 1

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

NCT ID: NCT06383390

The TRIUMPH-OUTCOMES study is looking at a new treatment called retatrutide, which is given once a week, to see if it can help reduce serious heart problems and protect kidney function in adults wh...

Recruiting

Phase: PHASE3 Conditions: Chronic Kidney Disease (CKD), Atherosclerotic Cardiovascular Disease (ASCVD)

A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

NCT ID: NCT05458297

This clinical trial is studying a new treatment called zilovertamab vedotin for patients with certain types of B-cell lymphomas, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (...

Recruiting

Phase: PHASE2 Conditions: Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma +2 more

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

NCT ID: NCT06312176

This clinical trial is studying a new treatment option for patients with a specific type of breast cancer called hormone receptor positive and HER2 negative (HR+/HER2-). The researchers want to see...

Recruiting

Phase: PHASE3 Conditions: Breast Neoplasms

A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

NCT ID: NCT05617677

This clinical trial is studying a medication called deucravacitinib to see how well it works and how safe it is for people with moderate to severe Systemic Lupus Erythematosus (SLE), a condition th...

Recruiting

Phase: PHASE3 Conditions: Systemic Lupus Erythematosus

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

NCT ID: NCT06136559

This clinical trial is studying a new medication called nemtabrutinib (MK-1026) to see how it compares to two existing treatments, ibrutinib and acalabrutinib, for patients with chronic lymphocytic...

Recruiting

Phase: PHASE3 Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

NCT ID: NCT06008756

The CORALreef study is a clinical trial that is looking at a new medication called enlicitide decanoate, which is an oral treatment designed to help lower cholesterol and reduce the risk of serious...

Recruiting

Phase: PHASE3 Conditions: Arteriosclerosis, Hypercholesterolaemia

Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-3475-D46)

NCT ID: NCT05609968

This clinical trial is studying two different treatment options for adults with metastatic non-small cell lung cancer (NSCLC) that has a specific marker called PD-L1, which is found in at least 50%...

Recruiting

Phase: PHASE3 Conditions: Carcinoma, Non-Small-Cell Lung

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

NCT ID: NCT06170788

This clinical trial is studying a new treatment approach for patients with metastatic non-small cell lung cancer (NSCLC), specifically those whose tumors have a high level of a protein called PD-L1...

Recruiting

Phase: PHASE3 Conditions: Non-small Cell Lung Cancer (NSCLC)

Search All Trials Browse All Locations